These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6055884)

  • 41. [Cyclophosphamide dose, antileukemic action and immuno-inhibitor effect].
    Mathé G; Schneider M; Schwarzenberg L
    Rev Fr Etud Clin Biol; 1968; 13(7):695-6. PubMed ID: 4882148
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of AC-3579, a diazafluoranthen derivative, on murine leukemia P388 and L1210--I. In vivo study.
    Hildebrand J; Thys O; Atassi G; Debusscher L; Tagnon HJ
    Eur J Cancer (1965); 1973 Sep; 9(9):635-9. PubMed ID: 4279175
    [No Abstract]   [Full Text] [Related]  

  • 43. [The effect of glyoxal-bis (guanylhydrazone) on transplanted mouse leukemia].
    OETTGEN HF; BURCHENAL JH
    Medizinische; 1959 Jul; No 29-30():1362-4. PubMed ID: 14428349
    [No Abstract]   [Full Text] [Related]  

  • 44. The use of macromolecules as carriers of antitumor drugs.
    Szekerke M; Driscoll JS
    Eur J Cancer (1965); 1977 Jun; 13(6):529-37. PubMed ID: 880962
    [No Abstract]   [Full Text] [Related]  

  • 45. Synthesis and evaluation of N-deacetyl-N-glycosylalkylthiocolchicines as antileukemic agents.
    Shiau GT; De KK; Harmon RE
    J Pharm Sci; 1978 Mar; 67(3):394-7. PubMed ID: 641731
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cytotoxicity of methylglyoxal bis(guanylhydrazone) in combination with alpha-difluoromethylornithine against HeLa cells and mouse L1210 leukemia.
    Sunkara PS; Prakash NJ; Chang CC; Sjoerdsma A
    J Natl Cancer Inst; 1983 Mar; 70(3):505-9. PubMed ID: 6403743
    [No Abstract]   [Full Text] [Related]  

  • 47. Effectiveness of antileukemic agents in mice inoculated with leukemia L1210 variants resistant to 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) or 5-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4-carboxamide (NSC-82196).
    Kline I; Woodman RJ; Gang M; Venditti JM
    Cancer Chemother Rep; 1971 Feb; 55(1):9-28. PubMed ID: 5121657
    [No Abstract]   [Full Text] [Related]  

  • 48. Antileukemic activity of streptozotocin (NSC-85998) and its analogs.
    Bhuyan BK; Fraser TJ; Buskirk HH; Neil GL
    Cancer Chemother Rep; 1972 Dec; 56(6):709-20. PubMed ID: 4267348
    [No Abstract]   [Full Text] [Related]  

  • 49. Activity of the anthracycline agent, 7-con-O-methylnogarol (7-OMEN), administered orally to mice bearing P388 or L1210 leukemia.
    McGovren JP
    Cancer Treat Rep; 1980; 64(4-5):727-9. PubMed ID: 6448690
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of antileukemic agents in advanced leukemia L1210 in mice. IX.
    Kline I; Gang M; Tyrer DD; Venditti JM; Artis EW; Goldin A
    Cancer Chemother Rep 2; 1971 Apr; 2(1):65-133. PubMed ID: 5565539
    [No Abstract]   [Full Text] [Related]  

  • 51. Collateral sensitivity of resistant lines of mouse leukemias L1210 and L5178Y.
    Schmid FA; Hutchison DJ
    Cancer Res; 1972 Apr; 32(4):808-12. PubMed ID: 5014791
    [No Abstract]   [Full Text] [Related]  

  • 52. HYDROXYMETHYLGLYOXAL BISGUANYLHYDRAZONE.
    LOO TL; DION RL; DAVIDSON JD; ADAMSON RH
    J Med Chem; 1963 Nov; 6():819-20. PubMed ID: 14184964
    [No Abstract]   [Full Text] [Related]  

  • 53. The rationale of the chemotherapeutic regimes relative to present knowledge of cell and population kinetics.
    Cooper EH
    Proc R Soc Med; 1970 Jan; 63(1):84-6. PubMed ID: 5417791
    [No Abstract]   [Full Text] [Related]  

  • 54. [Aromatic N-mustard compounds. 1. Derivatives of 3-N, N-bis-(2-chlorethyl)amino-4-methylbenzoid acid].
    Cambanis A; Gericke D
    Arzneimittelforschung; 1975 Jan; 25(1):1-9. PubMed ID: 1173761
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vivo and in vitro effectivity of some platinum complexes.
    Balázová E; Hrubisko M; Ujházy V
    Neoplasma; 1984; 31(6):641-7. PubMed ID: 6395026
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Conformations, DNA binding parameters, and antileukemic activity of certain cytotoxic protoberberine alkaloids.
    Cushman M; Dekow FW; Jacobsen LB
    J Med Chem; 1979 Mar; 22(3):331-3. PubMed ID: 423218
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anticancer activity of the extracts of root, stem & leaf of Ervatamia heyneana.
    Chitnis MP; Khandalekar DD; Adwankar MK; Sahasrabudhe MB
    Indian J Exp Biol; 1971 Apr; 9(2):268-70. PubMed ID: 5092749
    [No Abstract]   [Full Text] [Related]  

  • 58. Synthesis and antileukemic activity of 5-substituted 2,3-dihydro-6,7-bis(hydroxymethyl)-1H-pyrrolizine diesters.
    Anderson WK; Corey PF
    J Med Chem; 1977 Jun; 20(6):812-8. PubMed ID: 874955
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of antileukemic agents employing advanced leukemia L1210 in mice. VII.
    Venditti JM; Sheldon DR; Goldin A
    Cancer Res; 1964 Jan; 24(1 Pt 1):145-210. PubMed ID: 5878215
    [No Abstract]   [Full Text] [Related]  

  • 60. [Evaluation of antileukemic activity of L-lysine-alpha oxidase from Trichoderma sp. in chemotherapeutic experiments].
    Khaduev SKh; Glazkova TIu; Vesa VS; Laugalene NF; Puodzhiute SP; Denis GI; Iurchenko NIa; Berezov TT
    Biull Eksp Biol Med; 1989 Oct; 108(10):476-7. PubMed ID: 2597765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.